Hunt Andrew W, Clegg Kathleen, Reyes Christina Delos, Riley-Behringer Maureen, Zyzanski Stephen, Werner James
University Hospitals Cleveland Medical Center, Cleveland, OH.
Case Western Reserve University School of Medicine, Cleveland, OH.
Addict Disord Their Treat. 2019 Mar;18(1):36-43. doi: 10.1097/ADT.0000000000000147.
All 50 states have implemented a Prescription Drug Monitoring Program (PDMP) in efforts to control prescription drug abuse. Many now mandate PDMP checks before clinicians prescribe controlled substances. The aim of this study was to characterize the associations between patient characteristics, red flags found on PDMP reports, and prescriber behavior at community mental health agencies.
Prescribers at 9 practice sites, in five regional community mental health centers, were recruited by a practice-based research network (PBRN) to participate in a Card Study. Prescribers completed a PDMP attitudes survey, and cards were completed for patients who had PDMP reports checked. Data were analyzed using descriptive and inferential statistics.
Thirty nine providers completed cards for n=249 unique patient encounters. Over 1/3 of all patients reported an addiction disorder (38%) or a diagnosis of chronic pain (34%). Twenty percent of PDMP reports were found to have red flags, most commonly multiple prescribers or multiple pharmacies. Red flags were associated with race (p<.0.05), presence of chronic pain (p<0.01), presence of an addiction diagnosis (p<0.05), use of opioids (p<0.001), and non-adherence with treatment (p<0.006). Among prescribers, red flags were associated with lower prescribing rates (p<0.01), and decisions to decrease dosage (p<0.002).
Red flags were commonly found on PDMP reports done in community mental health settings, and were associated with important patient characteristics and diagnostic factors. PBRN research methods can be leveraged to obtain real-time observational data about psychiatric prescribers' use of PDMP reports in clinical decision-making in different settings.
美国所有50个州都实施了处方药监测计划(PDMP),以控制处方药滥用。现在许多州要求临床医生在开具管制药品之前进行PDMP检查。本研究的目的是描述患者特征、PDMP报告中发现的警示信号与社区心理健康机构开方者行为之间的关联。
通过一个基于实践的研究网络(PBRN)招募了五个地区社区心理健康中心9个执业点的开方者参与一项卡片研究。开方者完成了一份PDMP态度调查,并为检查过PDMP报告的患者填写了卡片。使用描述性和推断性统计方法对数据进行分析。
39名提供者为n = 249次独特的患者诊疗填写了卡片。超过三分之一的患者报告患有成瘾障碍(38%)或被诊断为慢性疼痛(34%)。发现20%的PDMP报告存在警示信号,最常见的是多个开方者或多个药房。警示信号与种族(p < 0.05)、慢性疼痛的存在(p < 0.01)、成瘾诊断的存在(p < 0.05)、阿片类药物的使用(p < 0.001)以及治疗依从性差(p < 0.006)相关。在开方者中,警示信号与较低的处方率(p < 0.01)以及降低剂量的决定(p < 0.002)相关。
在社区心理健康环境中进行的PDMP报告中常见警示信号,并且与重要的患者特征和诊断因素相关。可以利用PBRN研究方法获取关于精神科开方者在不同环境下临床决策中使用PDMP报告的实时观察数据。